The pandemic of COVID-19 is, no doubt, a force-majeure circumstance, which has affected every domain of life. The pharmaceutical industry did not only have to ramp up production on a fast-track basis and force R&D activities, but also re-organise their logistics, as well as change their regular pattern of work and business procedures.